CompletedNot Applicable

AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract

China1,840 participantsStarted 2021-01-16

Plain-language summary

The purpose of our study was to assess the performance of esophagogastroduodenoscopy automatic quality-control system in real-time quality control of EGD.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 40-80 years old * Patients scheduled for white light EGD examination with anaesthesia * American Society of Anesthesiology risk class 1, 2 or 3 Exclusion Criteria: * Patients with known advanced esophageal or gastric cancer * Patients with a history of esophageal or gastric surgery * Patients scheduled for therapeutic EGD * Patients with stenosis or obstruction of upper gastrointestinal tract * Patients with a history of serious anesthesia-related complications * Patients in pregnancy or lactation phase * Patients refused to sign the informed consent

What they're measuring

Detection rate of early cancer and precancerous lesions on upper gastrointestinal tract confirmed by pathological examination

Timeframe: 6 months

Trial details

NCT IDNCT04720924

SponsorShandong University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Esophagogastroduodenoscopy trials